Explore groundbreaking studies, experimental findings, and scientific advancements shaping the future of regenerative medicine
Discover how imetelstat, a pioneering telomerase inhibitor, shows unprecedented survival benefits for high-risk myelofibrosis patients who failed JAK inhibitor therapy.